NeuroOne Medical Technologies
NMTC
34 hedge funds and large institutions have $12.8M invested in NeuroOne Medical Technologies in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
39% more capital invested
Capital invested by funds: $9.18M → $12.8M (+$3.62M)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
13% more funds holding
Funds holding: 30 → 34 (+4)
0.27% more ownership
Funds ownership: 4.53% → 4.8% (+0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$748K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$306K |
| 3 |
Renaissance Technologies
New York
|
+$183K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$121K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$949K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$45.2K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$27.1K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$26.1K |
| 5 |
HF
HRT Financial
New York
|
-$13K |
NMTC Hedge Fund Activity: Q3 2025 in Review
34 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2025, worth a combined $12.8M — up 39% from $9.18M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NMTC positions and 5 closed out — a net gain of 4 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $748K. The largest seller was Sio Capital Management, cutting an estimated $949K.
- 34 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2025, up from 30 in Q2 2025.
- Funds reported $12.8M of NeuroOne Medical Technologies stock for Q3 2025, up 39% quarter-over-quarter.
- 9 funds opened new NeuroOne Medical Technologies positions in Q3 2025 and 5 closed out, a net change of +4 holders.
- The largest NeuroOne Medical Technologies buyer in Q3 2025 was AWM Investment Company, an estimated $748K added.
- The largest NeuroOne Medical Technologies seller in Q3 2025 was Sio Capital Management, an estimated $949K sold.
Based on aggregated 13F filings for Q3 2025.